Replies to post #486588 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

The number of doses will be determined by clinicians and regulators while there's a fixed cost to produce them all at once in a single run.

So as the number of doses increases, if the clinician thinks needed and guidance premits more, the costs do not go up beyond the labor needed for administration of the vaccine which isn't high.

It's not expensive to freeze a small vial especially when Advent can offset those storage costs by providing that service to other clients!

You are padding numbers in an attempt to win an argument. It's a futile effort. I appreciate your detailed analysis of the science behind DCVax but you are wrong on this issue!